Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
12.21
-0.16 (-1.29%)
Feb 21, 2025, 4:00 PM EST - Market closed
Tourmaline Bio Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$54.00
Upside
+342.26%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $25 | Buy | Reiterates | $25 | +104.75% | Dec 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +301.31% | Dec 11, 2024 |
BMO Capital | BMO Capital | Buy Initiates $50 | Buy | Initiates | $50 | +309.50% | Dec 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $49 | Strong Buy | Maintains | $48 → $49 | +301.31% | Nov 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +293.12% | Aug 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +293.12% | May 14, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +506.06% | Mar 25, 2024 |
Jefferies | Jefferies | Strong Buy Maintains $41 → $72 | Strong Buy | Maintains | $41 → $72 | +489.68% | Mar 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +293.12% | Mar 20, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $41 | Strong Buy | Initiates | $41 | +235.79% | Dec 15, 2023 |
Truist Securities | Truist Securities | Strong Buy Initiates $43 | Strong Buy | Initiates | $43 | +252.17% | Nov 17, 2023 |
Guggenheim | Guggenheim | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +309.50% | Oct 31, 2023 |
Piper Sandler | Piper Sandler | Buy Initiates $65 | Buy | Initiates | $65 | +432.35% | Oct 25, 2023 |